Hormonotherapy of advanced prostate cancer

被引：14
|
作者：
Pronzato, B. [1 ]
Rondini, M. [1 ]
机构：
[1] Felettino Hosp, Dept Oncol, La Spezia, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
prostate cancer; metastatic; hormonotherapy;
D O I：
10.1093/annonc/mdi913
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
More than two decades of studies on hormonal treatment of Prostate Cancer are briefly reviewed. Recent American Society of Clinical Oncology recommendations have pointed the major issues faced in randomized clinical trials and meta-analyses. Androgen ablation remains the mainstay of treatment for advanced stages, while Docetaxel based chemotherapy is becoming the standard in hormonorefractory tumors and targeted therapies are approaching.
引用
收藏
页码：80 / 84
页数：5
相关论文
共 50 条
  • [1] Association of radiotherapy and hormonotherapy in locally advanced prostate cancer
    Quero, Laurent
    Wong-Hee-Kam, Stephanie
    Rivera, Sofia
    Hennequin, Christophe
    [J]. BULLETIN DU CANCER, 2012, 99 : S30 - S36
  • [2] HORMONODEPENDENCE AND HORMONOTHERAPY IN CANCER OF PROSTATE
    JURET, P
    ALPERINE, G
    [J]. JOURNAL DE RADIOLOGIE D ELECTROLOGIE ET DE MEDECINE NUCLEAIRE, 1974, 55 (11): : 802 - 804
  • [3] 6-MONTH HORMONOTHERAPY IN ADVANCED PROSTATE CANCER: WHAT IS NEW ABOUT ANXIETY?
    De La Taille, Alexandre
    Mardoyan, Seta
    Lafaye, Anais
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E391 - E391
  • [4] Optimal sequence of hormonotherapy in advanced breast cancer
    Bertelli, Gianfilippo
    Paridaens, Robert
    [J]. CURRENT OPINION IN ONCOLOGY, 2006, 18 (06) : 572 - 577
  • [5] COMBINATION HORMONOTHERAPY WITH TAMOXIFEN AND FLUOXYMESTERONE IN PATIENTS WITH ADVANCED BREAST-CANCER RELAPSING ON HORMONOTHERAPY
    LEUENBERGER, U
    GOLDHIRSCH, A
    CAVALLI, F
    RYSSEL, HJ
    SONNTAG, RW
    JOSS, RA
    BRUNNER, KW
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (08): : 943 - 943
  • [6] COMBINATION HORMONOTHERAPY WITH TAMOXIFEN AND FLUOXYMESTERONE IN PATIENTS WITH ADVANCED BREAST-CANCER RELAPSING ON HORMONOTHERAPY
    GOLDHIRSCH, A
    LEUENBERGER, U
    RYSSEL, HJ
    CAVALLI, F
    SONNTAG, RW
    JOSS, RA
    BRUNNER, KW
    [J]. ONCOLOGY, 1982, 39 (05) : 284 - 286
  • [7] CHEMO-HORMONOTHERAPY OF ADVANCED BREAST-CANCER
    MASSIDDA, B
    FARRIS, A
    MASCIA, V
    FRATI, L
    CADAU, ML
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1983, 19 (03): : R27 - R27
  • [8] Hormonotherapy in Prostate Cancer Influences Tumor Microvessel Density: New Perspectives for Prostate Cancer Treatment?
    Santi, R.
    Comperat, E.
    Masieri, L.
    Serni, S.
    Camparo, P.
    Carini, M.
    Nesi, G.
    [J]. MODERN PATHOLOGY, 2013, 26 : 246A - 246A
  • [9] Second-generation hormonotherapy in prostate cancer and bone microenvironment
    Bouleftour, Wafa
    Boussoualim, Karima
    Sotton, Sandrine
    Vassal, Cecile
    Thomas, Thierry
    Magne, Nicolas
    Guillot, Aline
    [J]. ENDOCRINE-RELATED CANCER, 2021, 28 (08) : T39 - T49
  • [10] GENETIC VARIABILITY WITHIN 8Q24 IS ASSOCIATED WITH AGGRESSIVENESS OF ADVANCED PROSTATE CANCER SUITABLE FOR HORMONOTHERAPY
    Drouin, S. J.
    Roupret, M.
    Bitker, M. O.
    Azzouzi, A. R.
    Mallick, S.
    Vincendeau, S.
    Mangin, P.
    Valeri, A.
    Guy, L.
    Ruffion, A.
    Grima, F.
    Sebe, P.
    Cancel-Tassin, G.
    Cussenot, O.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 243 - 243
12345